-
Mashup Score: 0
The USPSTF just lowered the recommended screening age for breast cancer from 50 to 40. What were the reasons for this change and what are the potential harms and benefits?
Source: Lown InstituteCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
The USPSTF just lowered the recommended screening age for breast cancer from 50 to 40. What were the reasons for this change and what are the potential harms and benefits?
Source: Lown InstituteCategories: Healthcare Professionals, Latest HeadlinesTweet-
Earlier screening for breast cancer: Benefits and harms https://t.co/bfbWHBoa6X This is an excellent @lowninstitute analysis of the draft #USPSTF statement lowering the breast cancer screening start age from 50 to 40 years - driven less by new data than different values.
-
-
Mashup Score: 2
Clinicians should know the rough probability of a patient having a certain disease based on their symptoms and test results. Yet health care practitioners are not as good as you might expect at predicting patients’ disease risk, a new study finds.
Source: Lown InstituteCategories: Future of Medicine, Latest HeadlinesTweet-
🚨Clinicians consistently overestimate disease risk. #AI #medicine #ChatGPT #digitalhealth @lowninstitute https://t.co/e5Vb9kSQWr
-
-
Mashup Score: 2
An ongoing lawsuit focusing on the FDA’s approval of the abortion pill mifepristone could open the door to drug regulatory chaos.
Source: Lown InstituteCategories: General Medicine News, Latest HeadlinesTweet-
The slippery slope of the mifepristone and the FDA - Lown Institute https://t.co/oTA6X34diS
-
-
Mashup Score: 0New FDA guidelines on breast density notifications and implications for overuse - Lown Institute - 1 year(s) ago
The FDA just updated guidelines to require mammography facilities to notify patients about their breast density. How will this impact overdiagnosis and overtreatment?
Source: Lown InstituteCategories: Hem/Oncs, Latest HeadlinesTweet-
New @US_FDA guidelines on breast density notifications and implications for overuse https://t.co/7Klp1jvm06 via @JudiTheGarber @barttels2 @RogueRad
-
-
Mashup Score: 0
To understand the impacts of social determinants of health, bioethics, and the history of this country, one must also understand the overlap of intersectional identities.
Source: Lown InstituteCategories: General Medicine News, Latest HeadlinesTweet-
The Intersection of Black History, Queer Studies, and Medicine - Lown Institute https://t.co/cKCWjrCZjL
-
-
Mashup Score: 02022 Shkreli Awards - Lown Institute - 1 year(s) ago
It’s the 6th year of the Shkreli Awards, a top ten list of the worst examples of profiteering and dysfunction in health care, named for the infamous “pharma bro” Martin Shkreli.
Source: Lown InstituteCategories: Hem/Oncs, Latest HeadlinesTweet-
Gotta love the non-profit Lown Institute naming @BonSecours #3 on its list of Shkreli Awards featuring the 10 "worst examples of profiteering and dysfunction in health care" for its abuse of the federal #340B drug discount program. https://t.co/UQCjs8bk6D
-
-
Mashup Score: 12022 Shkreli Awards - Lown Institute - 1 year(s) ago
It’s the 6th year of the Shkreli Awards, a top ten list of the worst examples of profiteering and dysfunction in health care, named for the infamous “pharma bro” Martin Shkreli.
Source: Lown InstituteCategories: General Medicine News, Latest HeadlinesTweet-
RT @philgalewitz: Congrats to @sjtribble of @KHNews for making the Top 10 in the 2022 Shkreli Awards...https://t.co/obSkHBDkpl
-
-
Mashup Score: 02022 Shkreli Awards - Lown Institute - 1 year(s) ago
It’s the 6th year of the Shkreli Awards, a top ten list of the worst examples of profiteering and dysfunction in health care, named for the infamous “pharma bro” Martin Shkreli.
Source: Lown InstituteCategories: Healthcare Professionals, Latest HeadlinesTweet-
I was pleased to again be a judge for the #shkreliawards, named for infamous “pharma bro” Martin Shkreli. Top 10 worst examples of healthcare profiteering & dysfunction. My votes for #1, 7 & 10 appear in the link, but I could’ve picked any of them. #MIM23 https://t.co/Rg0KPxY9JB
-
-
Mashup Score: 11As many as 25% of screening colonoscopies are unnecessary, study finds - Lown Institute - 1 year(s) ago
As many as 25% of screening colonoscopies are not consistent with national guidelines, according to a recent systematic review.
Source: Lown InstituteCategories: Healthcare Professionals, Latest HeadlinesTweet-
25% of screening colonoscopies are unnecessary, study https://t.co/O0dNaLGaas by @JudiTheGarber @lowninstitute @JosephFraiman, @ShannonBrownlee, et al: "...screening colonoscopy is regularly performed in the U.S. more often ... than recommended by national guidelines."
-
Earlier screening for breast cancer: Benefits and harms https://t.co/zteTrcLzw7 via @JudiTheGarber & @lowninstitute @susan_bewley @MichaelBaum11 @petersasieni @paulpharoah @SteveLaitner